MAPT and Alzheimer disease: Notably, the discovery of the Pin1-catalyzed cis/trans isomerization of phosphorylated S/T-P motifs in tau and APP and cis pT231-tau, but not trans pT231-tau, as an early and potent driver in MCI and AD, offers an attractive and promising therapeutic strategy for AD.